St. Clair Hospital

There are several urologic conditions routinely treated with da Vinci Surgery, including bladder cancer and various kidney disorders, but the primary use of da Vinci Surgery for urologic conditions is for treating prostate cancer.  Prostatectomy is the surgical removal of the prostate gland, and is considered the gold standard treatment for localized cancer. ¹
 

• 1 in 6 U.S. men will be diagnosed with prostate cancer²
• Prostate cancer is the 2nd leading cause of cancer death in U.S. men²
• Prostate cancer is the most common cancer (non-skin related) in men²
• More prostate cancer patients in the U.S. choose da Vinci Surgery as their treatment of choice than any other treatment available³

Why choose a da Vinci Prostectomy?

1. Effective cancer control⁴
2. Improved and early return of sexual function⁵

3. Improved and early return of continence⁶

Patient comment: 

“I have not taken a Tylenol during any part of this process.  It was pain-free.  I was out of the hospital in a day and a half.  Literally two weeks into my recovery I was building bird houses in my garage just to pass the time so I could get to the point where I would be released to go back to work.  I went to work in 4 weeks time after surgery completely dry, continent and with no restrictions at all.”
- Dennis Murray, da Vinci Prostatectomy patient

_________________

While clinical studies support the effectiveness of the da Vinci System when used in minimally invasive surgery, individual results may vary.  Surgery with the da Vinci Surgical System may not be appropriate for every individual.  Always ask your doctor about all treatment options, as well as their risks and benefits.  PN 870443 Rev. A 04/09

1. Prostate Cancer Clinical Guideline Update Panel.  Guideline for the management of clinically localized prostate cancer: 2007 update.  Linthicum (MD):  American Urological Association Education and Research, Inc.; 2007.  82 p.
2. “What are the Key Statistics About Prostate Cancer?”, American Cancer Society:  www.cancer.org, URL:  http://www.cancer.org/docroot/CRI/content/CRI_2_4_1X_What_are_the_key_statistics_for_prostate_cancer_36.asp
3. The current status of robotic pelvic survery:  results of a multinational interdisciplinary consensus conference; Wexner SD, Bergamaschi R, Lacy A, et al Received:  22 September 2008 / Accepted:  13 October 2008 / Published online:  27 November 2008, Springer Science+Business Media, LLC 2008
4. Tewari A, Raman JD, Chang P, Rao S, Divine G, Menon M.  Long-term survival probability in men with clinically localized prostate cancer treated either conservatively or with definitive treatment (radiotherapy or radical prostatectomy).  Urology.  2006 Dec;68(6):1268-74.
5. Buron, C., B. Le Vu, et al.  (2007).  Brachytherapy versus prostatectomy in localized prostate cancer:  Results of a French multicenter prospective medico-economic study.  Int J Radiat Oncol Biol Phys 67(3): 812-22.
6. Kaul S, et al.  Robotic Radical Prostatectomy with Preservation of the Prostatic Fascia: A Feasability Study.  Urology 66, 1261-1265.

_________________

^{1 Clain based on 2008 U.S. data.  Data on file at Intuitive Surgical, Inc.
2 Claim based on 2011 U.S. data.  Data on file at Intuitive Surgical, Inc.
3 Zelefsky, M.D., Eastham, J.A., Cronin, A.M., Fuks, A., Zhang, Z., Yamada, Y., Vickers, A., Scardino, P.T. Metastasis after radical prostatectomy or external beam radiotherapy for patients with clinically localized prostate cancer: a comparison of clinical cohorts adjusted for case mix. (2010) Journal of clinical oncology, 28 (9), pp. 1508-1513.
4 Cooperberg, M.R., Vickers, A. J., Broering, J. M and Carroll, P. R. (2010), Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer.  Cancer, 116:  5226-5234.  doi:  10.1002/cncr.25456}